Elizabeth Buck

Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition

Stuart Thomson, Elizabeth Buck, Filippo Petti et al. · Cancer Research · 2005 · 669 citations

Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor

Mark J. Mulvihill, Andrew Cooke, Maryland Rosenfeld-Franklin et al. · Future Medicinal Chemistry · 2009 · 307 citations · Full text

Ullmann Diaryl Ether Synthesis: Rate Acceleration by 2,2,6,6-Tetramethylheptane-3,5-dione

Elizabeth Buck, Zhiguo J. Song, David M. Tschaen et al. · Organic Letters · 2002 · 294 citations

Cesium Carbonate, Chemical Engineering, Cross-coupling Reaction +11

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors

Elizabeth Buck, Alexandra Eyzaguirre, Eric Brown et al. · Molecular Cancer Therapeutics · 2006 · 233 citations

Tumor Biology, Epidermal Growth Factor, Non–small-cell Lung +15

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak et al. · Molecular Cancer Therapeutics · 2010 · 216 citations

Igf-1r Inhibition, Tumor Biology, Signal Transduction +14